Treatment Protocol for COVID-19 Based on T2R Phenotype.

Mohamed A Taha1,2, Christian A Hall1,3, Colin J Shortess1

  • 1Rhinology and Skull Base Research Group, Baton Rouge General Medical Center, 8585 Picardy Ave., Suite 210, Baton Rouge, LA 70809, USA.

Viruses
|April 3, 2021
PubMed
Summary

Tailoring COVID-19 treatments to bitter taste receptor 38 (T2R38) phenotypes significantly impacts symptom duration. This personalized approach shows promise for improving patient outcomes in the ongoing pandemic.